Wen-shan Li

Title: Innovations and Contributions of Inventor Wen-shan Li

Introduction

Wen-shan Li is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical research, particularly in the development of compounds aimed at treating obesity and related disorders. With a total of four patents to his name, his work has garnered attention for its potential impact on public health.

Latest Patents

Wen-shan Li's latest patents include innovative compounds designed for various medical applications. One notable invention is the ATF3 induction compounds, which relate to treatments for obesity and obesity-related disorders. This invention provides chromanone derivatives that serve as ATF3 inducers, targeting conditions such as heart disease, hypertension, hyperlipidemia, and diabetes. Another significant patent involves sialyltransferase inhibitors, which are novel compounds aimed at treating diseases associated with the activation of sialyltransferase, including cancer, immune diseases, and inflammatory conditions.

Career Highlights

Throughout his career, Wen-shan Li has worked with esteemed institutions such as Academia Sinica and Taipei Medical University. His research has focused on developing therapeutic solutions that address critical health issues, showcasing his commitment to advancing medical science.

Collaborations

Wen-shan Li has collaborated with notable colleagues, including Heng Lin and Ming-jaw Don. These partnerships have contributed to the success of his research endeavors and the development of his patented inventions.

Conclusion

Wen-shan Li's innovative work in the field of medical research highlights his dedication to improving health outcomes through scientific advancements. His patents reflect a commitment to addressing significant health challenges, particularly in the realm of obesity and related disorders.